IP Library Granted Patent US 10,814,112
Granted Patent B2
US 10,814,112 · App. 15/726,634 · Granted Oct 27, 2020

Drug-impregnated encasement

Inventors: Mark Thomas Fulmer (Glenmoore, PA); David A. Armbruster (West Chester, PA); Robert Frigg (Bettlach, CH); Elliott A. Gruskin (Malvern, PA); Sean Hamilton Kerr (Oreland, PA)
Assignee: DePuy Synthes Products, Inc.
A61M31/002A61B17/68A61B17/70A61B17/72A61B17/8028A61C8/0013A61F2/04A61F2/06A61F2/07A61J3/00A61L27/54A61L31/148A61L31/16A61M37/00A61B2017/00004A61B2017/00893A61F2002/072A61F2002/30919A61F2210/0004A61F2250/0067A61J2200/00A61M2205/04Y10T156/1051
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,814,112
App. No.
15/726,634
Granted
Oct 27, 2020
Kind
B2
Abstract

A drug-impregnated sleeve for encasing a medical implant is provided. In one embodiment, the sleeve may include a body made of a biologically-compatible material that defines an internal cavity configured to receive the medical implant. In one embodiment, the biologically-compatible material is bioresorbable. The body may include a plurality of apertures, such as perforations or holes, extending from the cavity through the body. The sleeve may further include a first end, a second end, and a drug impregnated into the resorbable sheet. In one possible embodiment, the first end of the sleeve may be open for receiving the medical implant therethrough and the second end may be closed. The implant may be encased in the sleeve and implanted into a patient from which the drug is dispensed in vivo over time to tissue surrounding the implantation site. In one embodiment, the body is made from at least one sheet of a biologically-compatible material.

Claims (19)

1. A bone graft containment system comprising:

a biocompatible sleeve comprising a textile body made of one or more polymer fibers, the sleeve including

a top and a bottom,

a first end open for receiving a bone graft material, and

a second end, the second end including a seam closing the second end,

the sleeve defining an internal cavity configured to contain the bone graft material,

and a bone graft material disposed within the cavity.

2. The bone graft containment system according to claim 1 , wherein the sleeve comprises a biocompatible sheet.

3. The bone graft containment system according to claim 2 , wherein the sheet has a thickness in the range of about 0.02 mm to about 0.5 mm.

4. The bone graft containment system according to claim 2 , wherein the sheet has a thickness in the range of about 0.04 mm to about 0.1 mm.

5. The bone graft containment system according to claim 1 , wherein the textile body further comprises a bioresorbable coating layer on the one or more polymer fibers.

6. The bone graft containment system according to claim 1 , wherein the sleeve comprises a resorbable polymer or a mixture of resorbable polymers.

7. The bone graft containment system according to claim 1 , wherein the sleeve further comprises a first edge, the first edge having a seam closing the first edge.

8. The bone graft containment system according to claim 1 , wherein the bone graft material comprises bone marrow aspirate.

9. The bone graft containment system according to claim 1 , wherein the bone graft material comprises autograft material.

10. The bone graft containment system according to claim 1 , wherein the bone graft material comprises allograft material.

11. The bone graft containment system according to claim 1 , wherein the bone graft material comprises calcium phosphate bone substitute material.

12. The bone graft containment system according to claim 1 , wherein the sleeve further includes one or more drugs impregnated in the sleeve.

13. The bone graft containment system according to claim 12 , wherein the one or more drugs includes an antibiotic, antiseptic, analgesic, antineoplastic agent, bisphosphonate, growth factor, peptide, statin, or combination thereof.

Assignments (9)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S ADDRESS PREVIOUSLY RECORDED ON REEL 044932 FRAME 0365. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNORS INTEREST. Recorded Feb 23, 2018
From: SYNTHES USA, LLC
To: DEPUY SPINE, LLC
Reel/Frame 045430/0127 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2017
From: FULMER, MARK THOMAS; ARMBRUSTER, DAVID A.; GRUSKIN, ELLIOTT A.; KERR, SEAN HAMILTON
To: SYNTHES (U.S.A.)
Reel/Frame 044456/0016 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2017
From: SYNTHES GMBH
To: SYNTHES (U.S.A.)
Reel/Frame 044456/0035 →
CHANGE OF NAME Recorded Dec 21, 2017
From: SYNTHES (U.S.A.)
To: SYNTHES USA, LLC
Reel/Frame 044456/0065 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2017
From: FRIGG, ROBERT
To: SYNTHES GMBH
Reel/Frame 044455/0981 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2017
From: DEPUY SPINE, LLC
To: HAND INNOVATIONS LLC
Reel/Frame 044932/0528 →
CHANGE OF NAME Recorded Dec 21, 2017
From: HAND INNOVATIONS LLC
To: DEPUY SYNTHES PRODUCTS, LLC
Reel/Frame 044932/0657 →
CHANGE OF NAME Recorded Dec 21, 2017
From: DEPUY SYNTHES PRODUCTS, LLC
To: DEPUY SYNTHES PRODUCTS, INC.
Reel/Frame 044932/0739 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2017
From: SYNTHES USA, LLC
To: DEPUY SPINE, LLC
Reel/Frame 044932/0365 →
Continuity (5)
Continuation 15417409 · Jan 27, 2017
Continuation 14503594 · Oct 1, 2014
Continuation 12089574
Provisional Application 60726808 · Oct 13, 2005
Related Publication 20180085564A1 · Mar 29, 2018